Olakin 150mg
Olaparib
Olakin 150mg (Olaparib) is used as a maintenance treatment in BRCA-mutated ovarian, fallopian tube, or peritoneal cancer patients post-chemotherapy.
- Strengths 150mg
- Form Tablets
- Packaging Size 30 TAB
- Packaging Type Box
- Manufacturer ZISKA PHARMACEUTICAL
Description
Olakin 150mg contains Olaparib, a targeted cancer therapy used for the maintenance treatment of advanced ovarian, fallopian tube, or primary peritoneal cancer. It is specifically effective in patients with inherited (germline) or acquired (somatic) BRCA gene mutations. Olakin 150mg works by inhibiting the PARP enzyme, which helps cancer cells repair their DNA, thereby slowing cancer growth and improving outcomes. It is typically prescribed after a successful round of platinum-based chemotherapy. This medicine should only be taken under the guidance of an oncologist and after BRCA mutation testing.
Ingredients
- Olaparib
Usage
- Take orally as prescribed by your oncologist
- Usually taken twice daily, with or without food
- Do not crush or chew the tablets
Precautions
- Only for patients with confirmed BRCA gene mutation
- Not recommended during pregnancy or breastfeeding
- Monitor for symptoms like anemia, nausea, or fatigue
- Regular blood tests may be required
- Avoid use if allergic to Olaparib
More like this
Find related medicines from trusted suppliers. Explore similar products to ensure you get the right medication for your needs.
